Evidence map›Paper›PMID 42282108›Full record

ReviewBioImpacts : BI2026

Current advancements and future prospects in the biorefinery and hyper-production of astaxanthin from

Jafar Aghajani, Morteza Mirzaei, Ali Choopani, Hosna Abbasi, Fatemeh Shakeri, Ali Mohammad Latifi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BioImpacts : BI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jafar AghajaniApplied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-1363-2018
Morteza MirzaeiApplied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-5568-2422
Ali ChoopaniApplied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-9072-5085
Hosna AbbasiDepartment of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0009-0006-8216-3955
Fatemeh ShakeriApplied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0002-3576-1347
Ali Mohammad LatifiApplied Biotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0007-6320-1458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astaxanthin (AXT) is a valuable xanthophyll carotenoid extensively utilized across the nutraceutical, pharmaceutical, cosmetic, and aquaculture industries. While this high-demand compound is produced both synthetically and biologically, natural AXT derived from the microalga

Indexed as

AstaxanthinBiotechnological strategiesCRISPR-cas9Haematococcus pluvialisMetabolic engineeringPhotobioreactors

Identifiers

PMID42282108
PMCPMC13250407

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.